Nuvalent IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
Brodsky & Smith is investigating the boards of Personalis, Distribution Solutions Group, Cross Country Healthcare, Nuvalent, and Dana Incorporated for potential fiduciary duty breaches in connection with their proposed acquisitions. Personalis is being acquired by Tempus AI for $16.25 per share, representing a total enterprise value of $1.5 billion net of Tempus’ existing ownership. Distribution Solutions Group is being acquired by LKCM Headwater Investments for $35.00 per share in cash, with LKCM Headwater and its affiliates already owning approximately 79% of the company’s outstanding common stock. Cross Country Healthcare is being acquired by Knox Lane for $13.25 per share in an all-cash transaction valued at $437 million. Nuvalent is being acquired by GSK for $124.00 per share in cash in a deal valued at $10.6 billion. Dana is being acquired by Eaton in a transaction valued at approximately $5.1 billion, where Eaton shareholders will own at least 50.1% and Dana shareholders approximately 49.9% of the combined company at close, and Eaton will receive a cash distribution of approximately $1.1 billion. The investigations focus on whether the boards failed to conduct a fair process and whether the proposed transactions pay fair value to shareholders.
Nuvalent IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
Personalis IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
GSK plc
Cross Country Healthcare IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
Dana IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
Distribution Solutions Group IncInvestigation into board's fiduciary duties regarding acquisition fairness; outcome uncertain.
Eaton Corporation PLC
Tempus AI, Inc. Class A Common Stock